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Abstract
In large scale genetic association studies, a primary aim is to test for association be-
tween genetic variants and a disease outcome. The variants of interest are often rare,
and appear with low frequency among subjects. In this situation, statistical tests
based on standard asymptotic results do not adequately control the Type I error rate,
especially if the case:control ratio is unbalanced. In this paper, we propose the use
of permutation and approximate unconditional tests for testing association with rare
variants. We use novel analytical calculations to efficiently approximate the true Type
I error rate under common study designs, and in numerical studies show that the pro-
posed classes of tests significantly improve upon standard testing methods. We also
illustrate our methods in data from a recent case-control study, for genetic causes of a
severe side-effect of a common drug treatment.
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1 Introduction
Association studies are often performed for binary traits, providing new knowledge of the
genetic causes of human diseases, using data from case-control and cohort studies (Verhaaren
et al., 2015; Opherk et al., 2014; Danjou et al., 2015; Hoffmann et al., 2015). Recent ad-
vances in sequencing technology have made it practical to type essentially every variant on
the genome; to avoid spurious findings, very low Type I error rates must therefore be main-
tained (Hoggart et al., 2008). However, for the rare variants now being studied, standard
analytic approaches do not reliably achieve their nominal rates, (Li and Leal, 2008; Xing
et al., 2012; Ma et al., 2013) and may permit too many Type I errors. The problem can be
particularly severe when the ratio of cases to controls is extreme. Adjustments that maintain
control at the nominal rate can be conservative, leading to loss of power relative to methods
that control Type I errors more accurately.
In this paper, motivated by work in a case-control study of rhabdomyolosis, we develop
methods with improved control of the Type I error rate, when testing single rare variants
for association with binary traits. In Section 2, we explain a novel numerical method that
approximates the actual Type I error rate of a test statistic given sample size, significance
level, and a variant’s expected frequency; we also show how the same basic ideas can be
used in permutation and approximate unconditional tests, and how the ideas can be used
when adjusting for covariates. In Section 3, we give the results of the numerical studies
performed, demonstrating improvements over standard asymptotic tests. Section 4 applies
these methods to data from a case-control study of statin-related rhabdomyolysis, and we
conclude with a short discussion, including details of an R package that implements our
methods.
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2 Methods
With rare variants, homozygotes are so rare as to be negligible for analysis, and it suffices
to consider whether subjects have any copies of the variant present (G = 1) or not (G = 0).
This step also means it is simple to enumerate all possible datasets; given fixed numbers of
cases and controls (m1 and m0 respectively), we need only consider the number of cases (r1)
and controls (r0) with the variant (adjustment for covariates is considered in Section 2.3.).
For a variant with a given minor allele frequency (MAF ), following Ma et al. (2013), we
define expected number of minor allele carriers as EMAC = (m0 +m1)× (1− (1−MAF )2).
Under the null hypothesis of no association, it follows that
r1 ∼ Binom
(
m1,
EMAC
m0 +m1
)
r0 ∼ Binom
(
m0,
EMAC
m0 +m1
)
,
independently. Therefore, given a value of EMAC — or equivalently MAF — and the fixed
numbers of cases and controls in the study at hand, we can simply write down the probability
of seeing all possible datasets under the null hypothesis.
In theory, this direct enumeration allows exact calculation of the Type I error rate for any
test: the Type I error rate is the sum of the probabilities of the datasets for which a significant
test result is returned. Formally, a dataset (m0,m1, r0, r1) returns a significant test result
when its associated p-value p(r0, r1;m0,m1) ≤ α, where p(r0, r1;m0,m1) = P[ |T | ≥ Tobs;H0 ]
is the probability of test statistic T equaling or exceeding the observed value Tobs when the
null hypothesis holds. The Type I error rate of the test at nominal level α is then defined as
T1ER(α) =
∑
0≤r0≤m0,0≤r1≤m1
f(r0, r1;m0,m1, EMAC)1p(r0,r1;m0,m1)<α, (1)
where f(r0, r1;m0,m1, EMAC) denotes the probability of observing data r0, r1 under the
null hypothesis, given m0, m1, and a specific EMAC. Although not discussed further, the
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approach is easily adapted to p-values that use lower tail areas – below Tobs instead of above,
or two-sided tests that examine tail areas beyond ±Tobs.
In practice, the sum of (m0+1)×(m1+1) terms in (1) may be large, making computation
too slow for some purposes. However, for work on rare variants, almost all of the summands
contribute negligibly to the overall Type I error rate. A practical solution is therefore to
truncate the summation in (1) by zeroing-out terms that, in total, represent no more than a
small fraction of the Type I error rate.
Taking this approach, in our work we will zero-out terms in (1) representing datasets
for which r0 + r1 exceeds the upper 10
−12 quantile of the distribution of r1 + r0, i.e. of
Binom(m0 +m1,
EMAC
m0+m1
) (Figure 1 gives a graphical description of this process). By setting
these terms to zero, in this example, we therefore understate the Type I error rate by no
more than 10−12, which is acceptable given our focus on Type I error rates near α = 5×10−8,
and maintain practical computation times, even for large studies. For example, performing
this calculation for (m0,m1, EMAC) = (500, 500, 15) at α = 5 × 10−8 using the standard
Score test takes 0.05 seconds on a standard laptop. Without the zeroing-out method, the
calculation takes 15.3 seconds, i.e. more than 300 times faster. Our choice of α corresponds
to testing a million independent variants (Pe’er et al., 2008), a level that has been widely-
adopted as the standard for genome-wide work
We emphasize that this approximation of the Type I error rate is entirely general; any
test statistic T can be used, including the familiar Wald, Score, likelihood ratio test statistics
(see e.g. Ma et al. (2013)) or more sophisticated choices such as the Firth test (Firth, 1993;
Heinze et al., 2013). Accurate knowledge of these approximate tests enables users to better
compare their performance at the nominal α.
The formulation of Type I error rate in (1) and its approximation can also directly
inform construction of permutation and approximate unconditional tests, as we discuss in
Sections 2.1 and 2.2 below. We briefly discuss adjusting for covariates in Section 2.3, for
both forms of test.
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Figure 1: Possible datasets and their contribution to T1ER for the standard Score test, for
m0 = m1 = 1000 and EMAC = 15. In a), the red/green zones indicate datasets where
the standard score test is significant/not-significant at nominal α = 5× 10−8; the blue zone
shows terms that are not zeroed-out using the truncation described in Section 2. In b) the
same situation is shown, zoomed in and with box size proportional to the probability of
each dataset; the actual T1ER(α) is given by the sum of the box areas in the two red zones.
Zeroing-out contributions beyond the blue region, where r0+r1 > 50, gives an approximation
error in the p-value of no more than 10−12.
2.1 Permutation tests
The ability of permutation tests to provide accurate p-values for association testing under
minimal assumptions is well-know (Pitman, 1937; Huo et al., 2014; Nichols and Holmes,
2002; Anderson, 2001); where they are applicable, permutation tests are regarded by many
analysts as the ‘gold standard’ method. For quantitative traits, a major drawback is that
permutations must, in practice, be performed using random number generation (Boyett and
Shuster, 1977). For analysis of binary traits this is not needed; we can instead enumerate
all possible permutations and obtain accurate p-values.
Using the same notation as above, a permutation test requires an observed test statis-
tic, Tobs, calculated on the observed data (m0,m1, r0, r1). We shall consider test statistics
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from standard score, Wald, likelihood ratio, and Firth test approaches, thus providing a
permutation version of them. The test statistic is also calculated for each possible datasets
(m0,m1, r
′
0, r
′
1) obtained by permuting binary outcomes (e.g. case/control labels) among all
study subjects, or equivalently permuting the variant/non-variant carrier status among all
subjects. Under permutation, the total number of minor allele carriers is the same as in
observed data, that is, r0 + r1 = r
′
0 + r
′
1, and under the null hypothesis of no association the
probability of observing each dataset follows the hypergeometric distribution (Good, 2005):
f˜(r′0, r
′
1;m0,m1, r0 + r1) =
(
r0 + r1
r′1
)(
m0 +m1 − r0 − r1
m1 − r′1
)
/
(
m0 +m1
m1
)
The permutation p-value is then defined as
pperm(r0, r1;m0,m1) =
∑
r′0,r
′
1
f˜(r′0, r
′
1;m0,m1, r0 + r1)1|Tr′0,r′1 |≥|Tobs|
,
i.e. the sum of probabilities of datasets with the same number of allele carriers that result
in more extreme test statistics than Tobs. The datasets enumerated in this method are
illustrated in Figure 2.
Permutation tests are exact, in the sense that the observed Type I error rate will always
be less than or equal to α. This result is well-known and dates back to Fisher (Janssen
and Pauls, 2003). In particular, for the rare variant setting, permutation tests will be fairly
conservative. A mathematical explanation is given in the Appendix.
2.2 Approximate Unconditional (AU) tests
Approximate Unconditional (AU) tests (Storer and Kim, 1990) provide Type I error rates
closer to the nominal level than permutation approaches. Unlike permutation tests, AU tests
are not guaranteed to always strictly control the Type I error rate, but this anti-conservatism
(where it occurs at all) is usually very mild.
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Figure 2: Datasets used when calculating the p-value for the permutation version of the
Score test, for observed data (m0,m1, r0, r1) = (1000, 1000, 5, 10). The size of each square
corresponds to the probability of observing the corresponding dataset under the null hypoth-
esis. The p-value is represented by the sum of the areas of the squares in the two shaded
‘tails’ of the distribution, containing all datasets with Score test statistic at least as extreme
as the observed data.
Using the same notation as above, AU tests calculate a test statistic Tobs from the observed
data (m0,m1, r0, r1) and from all possible datasets (m0,m1, r
′
0, r
′
1) but without the restriction
that r0 + r1 = r
′
0 + r
′
1. The probability of observing each dataset under the null hypothesis
is calculated using fitted binomial distributions, i.e.
fˆ(r′0, r
′
1;m0,m1, r0, r1) =
(
m0
r′0
)(
m1
r′1
)(
r0 + r1
m0 +m1
)r′0+r′1(
1− r0 + r1
m0 +m1
)m0+m1−r′0−r′1
.
The AU test’s p-value is then defined as
pAU(r0, r1;m0,m1) =
∑
r′0,r
′
1
fˆ(r′0, r
′
1;m0,m1, r0, r1)1|Tr′0,r′1 |≥|Tobs|
, (2)
i.e. the sum of probabilities of datasets that result in more extreme test statistics than Tobs.
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We can then apply Equation (1) and write the Type I error rate as:
T1ER(α) =
∑
0≤r′0≤m0,0≤r′1≤m1
fˆ(r′0, r
′
1;m0,m1, EMAC)1pAU (r′0,r′1;m0,m1)<α, (3)
Compared to the permutation test, the AU test’s p-value sums over many more possible
datasets, allowing less crude approximation of the Type I error rate. This comes at the cost
of using the same data to fit the null binomial models, and hence losing guaranteed control
of the Type I error rate. However, in our setting a bigger practical concern is that taking a
na¨ıve approach to calculation in Equation (2) would require (m0 + 1)× (m1 + 1) evaluations
for each p-value, which may be a burden, as with Equation (1). A much quicker approach
that is still adequate in practice uses the same zeroing-out idea as before – we only sum
elements (r′0, r
′
1) in (2) for values of r
′
0 + r
′
1 between the upper and lower 10
−12 quantiles of
the Binom(m0 +m1,
r0+r1
m0+m1
) distribution.
The datasets enumerated in this method are illustrated in Figure 3. As with the calcu-
lation of Type I errors in Section 2, the zeroing out leads to a slight understatement of the
p-value compared to complete enumeration. However, understating the p-value by at most
2× 10−12 is a very minor concern when α = 10−8, several orders of magnitude greater, and
comes in return for a substantial speed increase. For example, computing an AU p-value
under the Score test with data (m0,m1, r0, r1) = (5000, 5000, 10, 50) takes 0.05 seconds on a
standard laptop with zeroing out and 28.4 seconds without, i.e. over 500 times faster.
The AU approach, like the permutation approach, is completely general, and AU versions
of any test can be implemented. We shall use standard Score, Wald, likelihood ratio and
Firth tests.
2.3 Adjusting for covariates
Both permutation and AU tests permit adjustment for covariates through stratification,
i.e. only using information about association from within groups of subjects for whom
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Figure 3: Datasets used when calculating p-value for the AU version of the Score test, for
observed data (m0,m1, r0, r1) = (1000, 1000, 5, 10). The size of each square corresponds to
the probability of observing the corresponding dataset under the null hypothesis. In a),
the p-value is represented by the sum of the areas of the squares in the two shaded areas,
containing all datasets with Score test statistics at least as extreme as the observed data. In
b), we show how truncation at the upper 10−12 quantile of the fitted distribution of r0 and
r1 would zero out many datasets, making calculation much quicker.
confounding factors (for example ancestry) are held constant (Clayton et al., 1993).
Extending the previous notation, for stratified tests we now refer to vectorsm0,m1, r0, r1,
each of length q, where q is the number of strata defined by the levels of one or more cate-
gorical covariates. Indexing strata by i, with 1 ≤ i ≤ q, for each stratum i the stratified test
enumerates all possible strata-specific datasets (m0i,m1i, r
′
0i, r
′
1i) such that r
′
0i+r
′
1i = r0i+r1i,
computing a test statistic for each. The test statistics Ti(r0i, r1i) from each strata are com-
bined (by default they are added) to produce a single test statistic for the whole dataset;
formally we define
Tr′0,r′1 =
q∑
i=1
Ti(r0i, r1i).
The p-value, which as before compares this single test statistic to what might have been
observed under the null, uses the hypergeometric distribution for each set of stratum-specific
10
counts. We write the probability of observing specific datasets as
fˆ(r′0, r
′
1;m0,m1, r0, r1) =
q∏
i=1
fˆi(r
′
0i, r
′
1i;m0i,m1i, r0i, r1i)
where fˆi(r
′
0i, r
′
1i;m0i,m1i, r0i, r1i) =
(
r0i + r1i
r′1i
)(
m0i +m1i − r0i − r1i
m1i − r′1i
)
/
(
m0i +m1i
m1i
)
,
and formally define the p-value as
pstrat.perm(r
′
0, r
′
1;m0,m1, r0, r1) =
∑
r′0,r
′
1
fˆ(r′0, r
′
1;m0,m1, r0, r1)1|Tr′0,r′1 |≥|Tr0,r1 |
,
i.e. the sum of probabilities of datasets that result in more extreme test statistics than Tobs,
where Tobs is the test statistic corresponding to the data that was observed.
The stratified AU test is constructed from the same steps as the permutation except for
three differences, described earlier in Section 2.2. First, the datasets considered for each
strata include any values of 0 ≤ r′0i ≤ m0i and 0 ≤ r′1i ≤ m1i. Second, the probabilities fˆ of
each dataset are constructed from fitting a null binomial model within each strata. Third,
summands within each strata are zeroed-out for which the total contribution is no more than
2× 10−12.
Our approach removes confounding effects by using stratified analysis. Implemented
carefully, there is little to choose between use of stratification versus model-based regression
adjustment. In line with Clayton and Hills (1993, Statistical Methods in Epidemiology, pg
273) we find it appealing that the stratification approach forces careful consideration of a
which confounders are a priori most important to adjust for, and for stratification approaches
to be based closely on the scientific question of interest. Moreover, categorizing confounding
into strata is the only approach under which our enumeration approach for exact inference
is feasible; regression-based alternatives with continuously-valued covariates and standard
computing resources would have to compute p-values by some form of Monte Carlo method,
with consequent Monte Carlo error and long compute times.
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3 Analytical calculation results
To illustrate analytical calculations, we set the total sample size to be N = 10, 000—close
to that seen in Section 4’s example—and considered case:control matching ratios of 1:1, 1:3,
and 1:19. We set the nominal significance level at α = 5 × 10−8, and use EMAC ranging
from 1 to 100.
Permutation and AU versions of Score, Wald, likelihood ratio and Firth tests were ex-
amined. For comparison we also computed the standard Score, Wald, likelihood ratio, Firth
tests, and Fisher’s exact test, which is itself a permutation test. For permutation, AU,
and standard tests we also considered a regularized Wald test, which avoids undefined test
statistics by adding 0.5 to each cell count when any count is zero.
As seen in Figure 4, the tests based on standard asymptotics do not adequately control
the Type I error rate. In the balanced design, the tests are overly conservative, with the
exception of the likelihood ratio test, which is anti-conservative. The Score test has very a
large Type I error rate under the 1:3 ratio, so is presented separately. This is also true under
the 1:19 ratio for the Score and Wald tests, which are omitted. The other tests continue
to be conservative, and the likelihood ratio test’s Type I error rate is too large over certain
ranges. The Firth test consistently performs the best.
In Figure 5, we see that the permutation tests improve upon most of the standard tests,
though remain more conservative than the regular Firth test. While these tests have the
advantage of being exact, as the case:control ratio becomes more unbalanced, the Type I error
rate becomes more conservative. Under the 1:19 ratio, all tests perform nearly identically,
with the exception of the unregularized Wald test.
In Figure 6, we see that the AU tests show a large improvement over standard and
permutation tests, especially in the AU likelihood ratio and AU Firth tests. Though they
are not exact, the excess Type I error rate is mild. Note that under the 1:19 ratio, the Firth
and likelihood ratio tests perform identically.
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4 Application: Rhabdomyolysis case-control study
The data comes from an exome-sequencing study, in which 9,763 subjects who used statins
were considered; 211 cases with rhabdomyolysis and 9,552 controls. The rationale for this
design are described in detail by Marciante et al. (2011). Our interest was primarily in
assessing if there existed rare genetic variants associated with developing rhabdomyolysis
in statin users. We defined ‘rare’ variants as those where less than or equal to 100 study
participants carried the minor allele. Variants with less than 5 minor allele carriers were also
removed, as these provide no ability to produce significant values at the low α threshold used
in this form of study. Finally, for quality control, we filtered out variants with a genotyping
rate of less than 0.85. Applying these filters left 161,428 variants, and there are no covariates
for which to adjust in this analysis.
We applied the AU and permutation versions of the likelihood ratio test, and the permu-
tation and standard Firth test to all variants. The entire analysis took approximately 6.5
hours on a shared server, using a single CPU. The AU version of the Firth test was not used
due to its high computational burden. The resulting QQ plot and a plot of the inflation (45
degree rotated QQ plot) observed are given in Figure 7.
While some granularity in the larger p-values is present on the left hand of both plots,
based on our numerical results, it is reasonable to expect that the AU likelihood ratio test
provides the best control of the Type I error rate. Applied to this dataset, we observe that
the AU likelihood ratio test results in significantly less inflation than the standard Firth
test. Therefore, we believe that the right-hand tail of variants with p-values declared to be
significant under the AU test are more accurate statements of statistical significance than
the other methods.
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5 Discussion
We have developed and implemented association tests for rare genetic variants, that control
Type I error rates better than standard asymptotic tests. Of the tests proposed in this paper,
the AU version of the likelihood ratio and Firth tests perform the best, particularly when
the ratio of cases to controls is extreme. However, the AU version of the Firth test has a
notably higher computational burden than competitors. Therefore, we recommend the the
AU likelihood ratio test, for large genome-wide studies. If an exact test is necessary, then
a permutation test is recommended; though conservative, it tends to show an improvement
over standard tests. We note that if the expected number of minor allele carriers is less than
20, then no test will perform adequately, and conservative control of the Type I error rate is
the best achievable property.
The methods described here have been implemented in an R package, AUtests. This
package contains the functions basic.tests, perm.tests, and au.tests, which imple-
ment all the respective standard, permutation, and AU tests for a given vector of counts
(m0,m1, r0, r1), returning a vector of p-values. The AU Firth test is implemented in a sep-
arate function, au.firth, due to its increased computational time. For a typical dataset
(m0,m1, r0, r1) = (10000, 10000, 50, 50), on a standard laptop, the basic.tests function
takes 0.03 seconds of CPU time, the perm.tests function takes 0.21 seconds, the au.tests
function takes 0.39 seconds, and the au.firth function takes 51 seconds. To account for co-
variates, appropriately categorized, the package also contains the functions au.test.strat
and perm.test.strat, which implement stratified AU and permutation likelihood ratio
tests. The package is available on CRAN.
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Figure 4: T1ER versus EMAC for various standard tests at α = 5× 10−8 (dotted line) and
total N=10,000, grouped by matching ratio. All calculations use the zeroing-out technique
of Section 2, and so understate the true T1ER by no more than 10−12. Score and Wald tests
are omitted from the final plot due to gross violation of the nominal α.
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Figure 5: T1ER versus EMAC for permutation versions of standard tests as described in
Section 2.1 at α = 5 × 10−8 (dotted line) and total N=10,000, grouped by matching ratio.
All T1ER rate calculations use the zeroing-out technique of Section 2, and so understate
the true T1ER by no more than 10−12.
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Figure 6: T1ER versus EMAC, for AU versions of standard tests as described in Section 2.2,
at α = 5×10−8 (dotted line) and total N=10,000, grouped by matching ratio. All T1ER rate
calculations use the zeroing-out technique of Section 2, and so understate the true T1ER by
no more than 10−12.
18
0Figure 7: QQ plot and 45 degree rotated QQ plot of -log10 p-values for rhabdomyolysis
dataset, as described in Section 4. After quality control filtering, 161,428 variants are ana-
lyzed, with between 5 and 100 minor allele carriers each. For each method, the QQ plot shows
the ordered p-values versus the corresponding expected value from null, i.e. Uniform(0,1)
p-values. The blue cone shape indicates pointwise 95% prediction bounds for each ordered
p-value. The rotated plot shows the same results, but where the y-axis shows the -log10 ob-
served p-value minus the -log10 expected p-value; the blue cone has the same interpretation
as before.
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A Appendix: exact control of permutation tests
In this appendix, we show that permutation tests give exact control of the Type I error
rate. Rewriting equation (1) as a double summation over the observed minor allele count
(t := r0 + r1) and the number of these in the controls, we obtain
T1ER(α) =
∑
0≤t≤m0+m1
g(t;m0,m1)
∑
r0
f(r0;m0,m1, t)1p(r0,r1;m0,m1)<α
where g() denotes the probability of the observed minor allele count, and f() gives the
probability of the observed counts in cases and controls given the minor allele count r0 + r1
— so f() supports values of r0 between max(0, t−m1) and min(m0, t).
By construction, the inner sum always gives a value less than or equal to α; the outer
sum averages these, and so is similarly bounded. However, particularly for rare variants, the
inner sum considers a small set of possible permutations, as illustrated in Figure 2. While
this makes the test fast enough that zeroing-out is not required, it means that for small α,
the actual Type I error rate, while below α, will be quite conservative for many values of m0
and m1.
B Appendix: AU test power calculations
In this section, we show power calculations for the AU Firth test, under the same scenarios
considered in the main paper. We observe that power decreases as case:control matching
ratios become more skewed. In particular, the extremely unbalanced 1:19 ratio requires a
very large association in order to have meaningful power, even at higher minor allele counts.
20
Figure 8: Power curves giving the probability of rejecting the null hypothesis of independence
by expected minor allele count. Different curves correspond to different odds ratios. Each
panel corresponds to a different case:control matching ratio with an overall sample size of
20,000. Left: 1:1, middle: 1:3, right: 1:19 ratio
21
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